Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Mainz Biomed (MYNZ) Invested Capital (2020 - 2025)

Mainz Biomed's Invested Capital history spans 5 years, with the latest figure at $7.1 million for Q4 2024.

  • For Q4 2024, Invested Capital fell 12.83% year-over-year to $7.1 million; the TTM value through Dec 2024 reached $7.1 million, down 12.83%, while the annual FY2024 figure was $7.1 million, 12.83% down from the prior year.
  • Invested Capital for Q4 2024 was $7.1 million at Mainz Biomed, down from $8.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $14.2 million in Q4 2022 and bottomed at -$2.7 million in Q4 2020.
  • The 5-year median for Invested Capital is $7.1 million (2024), against an average of $6.6 million.
  • The largest annual shift saw Invested Capital skyrocketed 340.12% in 2021 before it tumbled 42.79% in 2023.
  • A 5-year view of Invested Capital shows it stood at -$2.7 million in 2020, then skyrocketed by 340.12% to $6.4 million in 2021, then skyrocketed by 120.11% to $14.2 million in 2022, then crashed by 42.79% to $8.1 million in 2023, then dropped by 12.83% to $7.1 million in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Invested Capital are $7.1 million (Q4 2024), $8.1 million (Q4 2023), and $14.2 million (Q4 2022).